Replies to post #19 on Groupe Gorge SA (EU:GOE) (GGRGF)

[BiotechValues]

Agreed on both points. What I like about GOE right now is that it's NOT trading on a US exchange.

The extra step or two involved in buying shares on the NYSE Euronext will discourage some US investors from bothering to buy it, regardless of the deep value (IMO) it represents here compared to peers.

But the beauty of it is, the CEO has a background in both engineering and finance. He's also the majority shareholder.

And he said yesterday that if the shares don't perform on the NYSE Euronext..."If this was to last for long, we could envisage any financial strategy that enables us to reach the huge financial leverage our competitors have."

So it looks like he wants to wait and see how the stock does trading there first.

So either:

1. The stock appreciates a great deal from here on the NYSE Euronext

or

2. he'll simply move trading to the NYSE or Nasdaq. They meet requirements for listing here and any vote to do so would be approved if he wants it to as the majority owner.


Raphael Gorge is no dummy.

[mstrike]

So maybe is better to wait for listing in US?